Broncus Medical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Broncus Medical, Inc. - overview
Established
1997
Location
San Jose, CA, US
Primary Industry
Medical Devices & Equipment
About
Founded in 1997 and based in California, US, Broncus Medical, Inc. develops and commercializes medical devices to treat patients with lung diseases. The company was founded by Glen French and in September 2021, Broncus Medical, Inc. raised HKD 1.
55 billion in an IPO (initial public offering) at HKD 18. 7 per share on the HKSE (Hong Kong Stock Exchange). The company develops various medical devices such as LungPoint Virtual Bronchoscopic Navigation Systems, an image-guided device that helps physicians to plan bronchoscopic procedures and navigate tumors in the lungs. An 18 gauge coring needle called FleXNeedle is used for peripheral sampling and access to inaccessible areas of the lungs.
Broncus Medical, Inc. also offers Archimedes System, a platform that utilizes BTPNA (Bronchoscopic Trans-Parenchymal Nodule Access) for nodule, vessel mapping, airway mapping, pathway guidance, and intra-operative fluoroscopy imaging. The company generated a revenue of USD 8. 072 million in 2019 and USD 3.
259 million in 2020. Broncus Medical, Inc. plans to boost its research and development efforts and commercialize its products.
Current Investors
Abingworth, Menlo Ventures, HBM Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices, Monitoring Equipment, Medical Equipment Distributors, Diagnostic Equipment
Website
www.broncus.com
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.